Literature DB >> 35467285

Purification and Phosphoproteomic Analysis of Plasma-Derived Extracellular Vesicles.

Anton B Iliuk1.   

Abstract

A successful phosphoproteomics analysis of extracellular vesicles (EVs) requires a unique approach, fine-tuned to address the challenges that have plagued plasma-based biomarker discovery. Here, I detail a procedure, which combines EVtrap-based high-recovery EV isolation, phase-transfer surfactant method for protein extraction, and PolyMAC-based enrichment of phosphopeptides. The combination of these methods provides a highly effective strategy for EV-based phosphoproteome analysis and leads to the discovery of novel phospho-markers previously undetectable.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  EVtrap; Exosomes; Extracellular vesicles (EVs); Liquid biopsy; Phosphoproteomics; Plasma

Mesh:

Substances:

Year:  2022        PMID: 35467285      PMCID: PMC9437911          DOI: 10.1007/978-1-0716-2341-1_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

Review 1.  Signaling--2000 and beyond.

Authors:  T Hunter
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  In-depth analyses of kinase-dependent tyrosine phosphoproteomes based on metal ion-functionalized soluble nanopolymers.

Authors:  Anton B Iliuk; Victoria A Martin; Bethany M Alicie; Robert L Geahlen; W Andy Tao
Journal:  Mol Cell Proteomics       Date:  2010-06-17       Impact factor: 5.911

4.  Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays.

Authors:  Jun Li; Wei Zhao; Rehan Akbani; Wenbin Liu; Zhenlin Ju; Shiyun Ling; Christopher P Vellano; Paul Roebuck; Qinghua Yu; A Karina Eterovic; Lauren A Byers; Michael A Davies; Wanleng Deng; Y N Vashisht Gopal; Guo Chen; Erika M von Euw; Dennis Slamon; Dylan Conklin; John V Heymach; Adi F Gazdar; John D Minna; Jeffrey N Myers; Yiling Lu; Gordon B Mills; Han Liang
Journal:  Cancer Cell       Date:  2017-02-13       Impact factor: 31.743

Review 5.  The current status of the clinical utility of liquid biopsies in cancer.

Authors:  Anson Snow; Denaly Chen; Julie E Lang
Journal:  Expert Rev Mol Diagn       Date:  2019-09-08       Impact factor: 5.225

Review 6.  Microvesicles as mediators of intercellular communication in cancer--the emerging science of cellular 'debris'.

Authors:  Tae Hoon Lee; Esterina D'Asti; Nathalie Magnus; Khalid Al-Nedawi; Brian Meehan; Janusz Rak
Journal:  Semin Immunopathol       Date:  2011-02-12       Impact factor: 9.623

7.  Unbiased quantitation of Escherichia coli membrane proteome using phase transfer surfactants.

Authors:  Takeshi Masuda; Natsumi Saito; Masaru Tomita; Yasushi Ishihama
Journal:  Mol Cell Proteomics       Date:  2009-09-18       Impact factor: 5.911

Review 8.  Exosomes: novel biomarkers for clinical diagnosis.

Authors:  Jin Lin; Jing Li; Bo Huang; Jing Liu; Xin Chen; Xi-Min Chen; Yan-Mei Xu; Lin-Feng Huang; Xiao-Zhong Wang
Journal:  ScientificWorldJournal       Date:  2015-01-27

9.  Multiplatform-based molecular subtypes of non-small-cell lung cancer.

Authors:  F Chen; Y Zhang; E Parra; J Rodriguez; C Behrens; R Akbani; Y Lu; J M Kurie; D L Gibbons; G B Mills; I I Wistuba; C J Creighton
Journal:  Oncogene       Date:  2016-10-24       Impact factor: 9.867

Review 10.  Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer's Biomarkers.

Authors:  Diego Fernández-Lázaro; Juan Luis García Hernández; Alberto Caballero García; Alfredo Córdova Martínez; Juan Mielgo-Ayuso; Juan Jesús Cruz-Hernández
Journal:  Diagnostics (Basel)       Date:  2020-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.